Author: admin

Medicines360, a non-profit pharmaceutical company, and Actavis, Inc., a leading global specialty pharmaceutical company, today announced a historic partnership to support Medicines360’s mission to reduce cost as a barrier to accessing women’s birth control. The Medicines360 and Actavis partnership will make the IUD available in the U.S. commercially and at a very low price in U.S.public sector clinics. As part of this agreement, Actavis has licensed the U.S. commercial rights for the Medicines360 LNG20 Intrauterine Device (IUD).

  • Posted in Press Releases
  • Comments Off on Actavis and Medicines360 Announce Partnership to Advance Women’s Access to Affordable IUDs

Medicines360, the US-based non-profit that addresses unmet medical needs of women and children by developing innovative, affordable and sustainable medical solutions, today announced a strategic partnership with European women’s health pharmaceutical company Uteron Pharma Operations (UPO), based in Liege Belgium, to develop a long-acting LNG IUD. As part of the collaborative agreement, Uteron is responsible for the design and manufacture of the product, and Medicines360 is responsible for Phase III clinical development.

  • Posted in Press Releases
  • Comments Off on Collaboration to Develop State-of-the-Art Levonorgestrel Releasing Intrauterine Device (LNG IUD) As Highly Effective Long-acting Reversible Contraceptive